Smartest Doc
Lessons from platelet inhibition and patient outcomes
Current Opinion in Cardiology, 06/26/2012
Held C – Among patients with an acute coronary syndrome (ACS) with or without ST–segment elevation, treatment with ticagrelor, as compared with clopidogrel, significantly reduced the rate of death from vascular causes, myocardial infarction, or stroke without an increase in the rate of overall major bleeding but with an increase in the rate of nonprocedure–related bleeding.